EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
Our Life Sciences Consulting team can help accelerate your journey to providing more engaging and customer-centric experiences. Find out how.
Read more
Deeper health equity insights
Leveraging digital technologies and data analytics can provide health organizations with deep insights into both patient population health and the underlying social drivers of health. With this understanding, these companies can develop personalized information and actionable insights to advance more equitable engagement and health care experiences. For example, companies can create composite risk scores around potential patient outcomes, individualized care plans and customer-centric experience strategies that enable frictionless interactions with patients.
By way of further example, having a robust data analytics framework in place can also help health companies identify and sharpen their health equity focus on specific conditions. To that end, we recently teamed with a health data startup to gain deeper insights into chronic kidney disease (CKD), which disproportionately impacts Black Americans. Powered by advanced data analytics tools, our analysis of claims data gathered from 2015 to 2022 on approximately 700,000 patients helped illustrate the drivers and barriers to care around CKD.¹
This analysis revealed that Black CKD patients were more likely to be diagnosed in the later stages of the disease than their White peers, often due to barriers to access that result in delayed engagement with the health care system. Black CKD patients were also more likely to visit an emergency department in the later stages of the disease, resulting in unnecessarily high costs of care and, ultimately, a higher economic burden on the health care system and the US economy. Importantly, we also observed that about 44% of excess risk for CKD among Black Americans is caused by modifiable risk factors around lifestyle, clinical conditions and structural drivers.
As the CKD example demonstrates, organizations have an untapped opportunity to leverage digital and data capabilities to identify and address health inequities. The actionable insights gleaned from these tools can help health care companies tackle similar barriers specific to underserved patient populations and preventable chronic conditions. For life sciences companies, this data can enable more inclusive health care experiences and drive commercial excellence.